FIELD: medicine. SUBSTANCE: method involves administering an amylene antagonist to a patient consuming no insulin at a dose reducing sugar concentration in blood. It is advised to treat the patients having HbA1c being equal to approximately 8% or higher. EFFECT: enhanced effectiveness in reducing blood sugar without consuming insulin. 12 cl, 1 dwg 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF OBESITY TREATMENT | 1998 |
|
RU2207871C2 |
| METHOD FOR TREATMENT OR PROPHYLAXIS OF OBESITY | 2002 |
|
RU2314121C9 |
| METHODS OF REGULATION OF GASTROENTERIC TRACT MOTOR SYSTEM | 1994 |
|
RU2177331C2 |
| METHOD FOR INHIBITING GLUCAGON | 2000 |
|
RU2247575C9 |
| ANALOG-AGONIST OF AMYLINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION EXHIBITING PROPERTIES OF AMYLINE AGONIST | 1992 |
|
RU2130463C1 |
| NEW COMPOSITIONS OF EXENDINE AGONISTS AND METHODS OF THEIR ADMINISTRATION | 2000 |
|
RU2242244C2 |
| METHOD FOR DECREASING OF NUTRIENT AVAILABILITY AND METHOD FOR APPETITE SUPPRESSION | 2001 |
|
RU2275207C2 |
| METHODS OF DIABETES TREATMENT AND BODY WEIGHT REDUCTION | 2006 |
|
RU2421237C2 |
| PEPTIDE HAVING AMYLIN PROPERTIES (VERSIONS) AND USE THEREOF (VERSIONS) | 2005 |
|
RU2385878C2 |
| RAPID ACCOMPLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STABLE DRUG DELIVERY | 2010 |
|
RU2753280C2 |
